Wellbutrin SR

Prodotti simili

Bupron SR

Prezzo da €42.54

Vedi

Bupropion

Prezzo da €45.95

Vedi

Wellbutrin

Prezzo da €56.16

Vedi

Zyban

Prezzo da €34.03

Vedi

Remeron

Prezzo da €34.89

Vedi

Mellaril

Prezzo da €34.03

Vedi

Wellbutrin SR—that name still gets a mixed reaction in the break room. I remember when it first started showing up in our formulary, back around the late 90s. We’d all been trained on the SSRIs, fluoxetine this, sertraline that, and here comes this weird aminoketone that looked nothing like the usual suspects. My first real encounter was with a 34 year old woman, let’s call her Maria, who’d been on paroxetine for about eight months. She was less depressed, sure, but she’d gained almost fifteen pounds, her libido was gone, and she told me point blank she’d rather feel miserable than keep going like that. I’d read the early bupropion data, but I was nervous. The seizure risk was still being talked about in hushed tones. I started her on 150 mg SR once daily, and I’ll be honest, I told her to call me the second she felt anything weird. She came back in three weeks looking like a different person. Not euphoric, not hypomanic, just… present. She’d lost four pounds, she said her sex drive was coming back, and she was sleeping normally. That case sold me. It also taught me that the sustained release formulation was the key—the immediate release stuff was just too spiky, too unpredictable.

What Is Wellbutrin SR and Why Does It Matter?

Wellbutrin SR (bupropion hydrochloride sustained-release) is an atypical antidepressant that belongs to the aminoketone class. It’s chemically unrelated to SSRIs, SNRIs, tricyclics, or MAOIs, which matters more than most people realize. The “SR” designation means sustained-release, a pharmacokinetic tweak that allows for twice daily dosing instead of the three times daily required with the immediate release version. The primary indication remains major depressive disorder, but its real-world use has expanded significantly, particularly for seasonal affective disorder and as a smoking cessation aid under the brand name Zyban. What sets it apart clinically is its side effect profile—or rather, what it doesn’t cause. Weight gain, sexual dysfunction, and sedation, which plague so many other antidepressants, are notably absent with bupropion. For a subset of patients, that’s the difference between staying on treatment and quitting altogether.

The Composition and Why Release Kinetics Matter

Each tablet of Wellbutrin SR contains 150 mg or 100 mg of bupropion hydrochloride. But the ingredient list isn’t where the magic is—it’s the delivery system. The SR formulation uses a wax matrix and hydroxypropyl methylcellulose to control dissolution. What this means practically is that instead of getting a sharp peak in plasma concentration an hour after swallowing, you get a gradual rise over about three hours, with sustained levels for another eight to twelve. This is not academic. The immediate release formulation, which still exists but is rarely prescribed, had a much higher incidence of seizures—about 0.4% at doses above 450 mg/day, compared to roughly 0.1% with SR. The difference isn’t the drug itself; it’s the peak concentration. When you flatten the curve, you reduce the risk. The bioavailability of bupropion is about 80%, but it undergoes extensive first-pass metabolism in the liver, primarily via CYP2B6, producing three active metabolites: hydroxybupropion, threohydrobupropion, and erythrohydrobupropion. Hydroxybupropion reaches plasma concentrations four to five times higher than the parent drug and has about half the potency, so it contributes meaningfully to both efficacy and side effects.

Mechanism of Action: The Norepinephrine and Dopamine Reuptake Inhibition Story

This is where I have to be careful, because the textbooks oversimplify it. Wellbutrin SR is classified as a norepinephrine-dopamine reuptake inhibitor (NDRI), but that label doesn’t tell the whole story. At therapeutic doses, bupropion weakly inhibits dopamine reuptake—about as weakly as any drug that actually works. The norepinephrine reuptake inhibition is more robust, but still modest compared to something like reboxetine. So how does it work? The current thinking, which I find convincing, is that bupropion acts as a functional antagonist at nicotinic acetylcholine receptors, specifically the α4β2 subtype. This is the same mechanism that makes it effective for smoking cessation. There’s also evidence it modulates the activity of the mesolimbic dopamine system indirectly, through its metabolite hydroxybupropion, which may explain why some patients experience a subtle motivational enhancement rather than the emotional blunting that SSRIs can produce. In clinical terms, patients often say they feel “more like themselves” rather than “happier.” It’s a distinction that matters. The onset of action is typically two to four weeks, though some patients report improvements in energy and concentration within the first week. That early response is usually a good prognostic sign.

What Is Wellbutrin SR Actually Effective For?

Major Depressive Disorder This is the FDA-approved indication, and the evidence base is solid. Multiple randomized controlled trials have demonstrated superiority over placebo, with response rates around 50-60% in the acute phase. What’s less well known is that bupropion SR appears to be particularly effective for the melancholic subtype of depression—patients with psychomotor retardation, hypersomnia, and hyperphagia. I’ve seen patients who slept twelve hours a night and still couldn’t get out of bed become functional within three weeks. It’s less effective for anxious depression, and in some cases can worsen anxiety, which is why I always screen for comorbid panic disorder before prescribing.

Seasonal Affective Disorder Wellbutrin SR is approved for prevention of SAD, and the data are actually quite good. A large multicenter trial showed that starting treatment in the fall and continuing through winter reduced the recurrence rate from about 30% to 16%. The dosing is straightforward—300 mg once daily starting in September or October, tapering off in March. I’ve had patients who used it for three consecutive winters and then stopped without recurrence. It’s not a cure, but it’s remarkably effective prophylaxis.

Smoking Cessation Under the brand name Zyban, bupropion SR doubles quit rates at 12 months compared to placebo. The mechanism is the nicotinic receptor antagonism I mentioned earlier, plus the attenuation of withdrawal symptoms, particularly irritability and depression. The standard protocol is 150 mg once daily for three days, then twice daily for seven to twelve weeks, with a target quit date in the second week. I’ve used it in combination with nicotine replacement therapy, which is safe and may be more effective than either alone.

ADHD (Off-Label) This is where I’ve seen some of the most interesting results, but also some of the biggest disappointments. Bupropion SR can improve attention and executive function in adults with ADHD, particularly those who cannot tolerate stimulants or have comorbid depression. The effect size is smaller than methylphenidate, about 0.4 compared to 0.8, but for the right patient it’s a game changer. I had a 28 year old graduate student who couldn’t tolerate amphetamine salts because of anxiety and insomnia. We tried bupropion SR 300 mg daily, and he reported improved focus without the jitteriness. His GPA went from 2.8 to 3.6 over two semesters. But I’ve also had patients who felt no benefit at all. The response is highly variable, and I can’t predict who will respond.

Instructions for Use and Dosing

The starting dose for major depressive disorder is 150 mg once daily in the morning. After three days, if tolerated, increase to 150 mg twice daily. The maximum recommended dose is 400 mg per day in divided doses, though I rarely exceed 300 mg. The tablets should be swallowed whole—crushing or chewing destroys the sustained release mechanism and can cause rapid absorption, increasing seizure risk. Missed doses should be skipped if remembered late in the day, because the drug can interfere with sleep. The course of treatment for acute depression is typically six to twelve weeks, but maintenance therapy for six to twelve months is recommended to prevent relapse. For SAD prophylaxis, treatment starts in the fall and continues through winter, usually four to six months.

Side Effects and What to Watch For

The most common side effects are dry mouth, insomnia, headache, nausea, and tremor. The insomnia is dose-dependent and often resolves if the second dose is taken no later than 4 PM. I tell patients to expect dry mouth and to keep water handy—it usually improves after two weeks. More concerning is the seizure risk, which is about 0.1% at doses up to 300 mg, rising to 0.4% at 400 mg and higher in patients with predisposing factors. Absolute contraindications include seizure disorders, current or prior diagnosis of bulimia or anorexia nervosa, and abrupt discontinuation of alcohol or sedatives. I also avoid it in patients with uncontrolled hypertension, because bupropion can raise blood pressure by about 5-10 mm Hg on average. I’ve seen a patient go into hypertensive crisis on 300 mg, though that was with undiagnosed pheochromocytoma, so it’s rare.

Contraindications and Drug Interactions

The list is short but absolute. Seizure disorder, eating disorders, MAOI use within 14 days, and pregnancy category C—meaning risk cannot be ruled out, though the data are limited. The most important drug interaction is with CYP2B6 inhibitors and inducers. Bupropion is metabolized primarily by CYP2B6, and drugs that inhibit this enzyme, like ticlopidine and clopidogrel, can increase bupropion levels significantly. Inducers like ritonavir and phenobarbital can reduce levels. There’s also a significant interaction with tamoxifen, which requires CYP2D6 for activation—bupropion inhibits CYP2D6, so concurrent use can reduce tamoxifen efficacy. This is a real clinical issue that many oncologists forget to check.

Clinical Evidence and What the Studies Actually Show

The landmark study was the 1994 paper by Settle et al., which demonstrated the efficacy of bupropion SR 300 mg/day in a six-week, double-blind, placebo-controlled trial. Response rates were 59% versus 29% for placebo. More recent meta-analyses, including a 2018 Cochrane review, confirm that bupropion is as effective as SSRIs for depression but with a different side effect profile. The STAR*D trial, which I reference constantly, showed that bupropion was an effective augmentation strategy for patients who failed to respond to citalopram—about 30% of non-responders achieved remission when bupropion was added. That’s a real-world number I trust more than any industry-sponsored trial.

Comparing Wellbutrin SR to Other Options

The main competitors are SSRIs like escitalopram and sertraline, and SNRIs like venlafaxine. The advantage of bupropion is the lack of sexual dysfunction and weight gain. The disadvantage is the seizure risk and the potential for anxiety. For patients with comorbid anxiety disorders, I usually start with an SSRI and consider bupropion as an augmenting agent. For patients with bipolar depression, bupropion may be safer than SSRIs because it has a lower risk of switching to mania, though I still use it cautiously with a mood stabilizer. I’ve seen a patient with bipolar II become hypomanic on 150 mg within a week—it’s not common, but it happens.

Frequently Asked Questions

Can Wellbutrin SR cause weight loss? Yes, but it’s modest and usually temporary. Average weight loss is about 2-3 pounds over three months, mostly in the first few weeks. I’ve had patients who lost more, but I don’t prescribe it for weight loss.

How long does it take to work? Most patients notice some improvement within two weeks, but full effect may take four to six weeks. I tell patients to give it at least six weeks before deciding it’s not working.

Can I drink alcohol while taking Wellbutrin SR? I advise against it, especially in the first month. Alcohol lowers the seizure threshold, and bupropion already increases it. A single drink is probably safe, but binge drinking is dangerous.

Is Wellbutrin SR addictive? No, it does not produce euphoria or withdrawal symptoms typical of addictive drugs. There is no evidence of abuse potential in clinical trials.

What happens if I miss a dose? Take it as soon as you remember, unless it’s close to bedtime, in which case skip it. Do not double up.

Conclusion: Lessons from Twenty Years of Prescribing

I’ve prescribed Wellbutrin SR to hundreds of patients over two decades. It’s not a first-line agent for everyone, but for the right patient, it’s transformative. The patients who do best are the ones with low energy, low motivation, and no significant anxiety. They’re the ones who tell me they feel like they’ve been “unstuck.” I’ve also seen it fail spectacularly in patients with panic disorder, who become more anxious and agitated. The key is patient selection, careful dosing, and honest communication about expectations.

One case that sticks with me: a 52 year old man, divorced, two kids in college, who’d been on sertraline for three years. He was euthymic but had gained 30 pounds, developed erectile dysfunction, and felt emotionally numb. He said, “Doctor, I’m not sad anymore, but I’m not anything.” We switched him to bupropion SR 150 mg twice daily. Six weeks later, he came back and said, “I’m still not sad, but now I’m also not dead inside.” He’d lost 12 pounds, his libido was back, and he’d started dating again. That’s the kind of outcome that makes this job worthwhile.

I still worry about the seizure risk, even though I’ve never seen a case in my practice. I still screen for eating disorders and seizure history like a broken record. But I also know that for a significant number of patients, this drug is the difference between existing and living. That’s why I keep prescribing it, and why I keep learning from every patient who trusts me with their care.